Article
Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
Annals of clinical microbiology and antimicrobials - 16 Jul 2018
Sowajassatakul Angkanang, Prammananan Therdsak, Chaiprasert Angkana, Phunpruch Saranya
Abstract excerpt
BACKGROUND: Aminoglycosides such as amikacin and kanamycin are effective injectable second-line drugs for treatment of multidrug-resistant tuberculosis. Molecular mechanisms underlying aminoglycoside resistance are not well understood. We have previously identified the amikacin- and kanamycin-resistant M. tuberculosis MT433 clinical strain, of which all known mutations related to resistance have not been found....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
